British journal of clinical pharmacology
-
Br J Clin Pharmacol · Aug 2007
Clinical TrialAge dependent systemic exposure to inhaled salbutamol.
To determine the effect of age on systemic exposure to inhaled salbutamol in children. ⋯ For similar systemic exposure, dosing should be adjusted to age or size but not on a fixed microg kg(-1) basis, which may lead to unnecessary suboptimal dosing.
-
Br J Clin Pharmacol · Aug 2007
Review Case ReportsCardiovascular toxicity due to venlafaxine poisoning in adults: a review of 235 consecutive cases.
Venlafaxine may increase the risk of arrhythmia in certain patients. We sought to characterize the cardiovascular effects of venlafaxine overdose in adults. ⋯ Venlafaxine overdose is associated with sympathomimetic cardiovascular effects and prolonged QTc, irrespective of coingested drugs. These mechanisms might pose an increased risk of arrhythmia and require further exploration.
-
Br J Clin Pharmacol · Jul 2007
Meta AnalysisThe use of mechanistic DM-PK-PD modelling to assess the power of pharmacogenetic studies -CYP2C9 and warfarin as an example.
To assess the power of in vivo studies needed to discern the effect of genotype on pharmacokinetics (PK) and pharmacodynamics (PD) using CYP2C9 and (S)-warfarin as an example. ⋯ The utilization of prior information (including in vivo enzymology) in clinical trial simulations can guide the design of subsequent in vivo studies of the impact of genetic polymorphisms, and may help to avoid costly, inconclusive outcomes.